OxiProteomics

OxiProteomics

CRO/CDMO

Created in 2014

11-20 employees

Innovative Scientific Services on Efficacy Testing for Bioactives or Formulated Products to Support Healthy Aging

OxiProteomics is a CRO French specialized in biomarker assessment providing research services for skin care dermo-cosmetics, medical devices, and dermatology efficacy evaluation. Spined-out from Sorbonne University in 2014, their uniqueness is a specific know-how on non-targeted & targeted proteomics approaches adapted to skin and hair evaluation.

OxiProteomics supports their clients on molecular target identification, target validation, efficacy testing, mechanistic studies, prediction of responders, and biomarkers discovery. They also propose predictive pre-clinical skin models coupled with spatial proteomics analyses, based on the organ culture of human skin samples.

OxiProteomics ables work with clinical samples to perform bio-analysis. They also mechanistic investigator-initiator trials with the analysis of biopsies and non-invasive samples.

CONTACT INFORMATION

Martin Baraibar

CEO & Founder

Paris, France

martin.baraibar@oxiproteomics.fr

LinkedIn

DISCOVER MORE

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *